| P2093 | author name string | Ameer Y Taha | |
| | Richard P Bazinet | |
| | Anthony F Domenichiello | |
| | Hye Jin Cho | |
| | Chuck T Chen | |
| | W M Burnham | |
| | Marc-Olivier Trépanier | |
| | Joonbum Lim | |
| | Terence K Y Lai | |
| P2860 | cites work | The biogenesis of chylomicrons | Q28833221 |
| | Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial | Q33988508 |
| | Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. | Q34014760 |
| | Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke | Q34250276 |
| | Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes | Q34401274 |
| | Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression | Q36535302 |
| | Antiepileptic drug-induced hypersensitivity syndrome reactions | Q37239402 |
| | Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons | Q37243012 |
| | Epidemiology and classification of epilepsy: gender comparisons | Q37301512 |
| | Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins | Q37661135 |
| | Polyunsaturated fatty acids and epilepsy | Q37770588 |
| | The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations | Q42520124 |
| | Genetic ablation of CD36 does not alter mouse brain polyunsaturated fatty acid concentrations | Q43122479 |
| | Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats | Q43162767 |
| | Assessing the metabolic and toxic effects of anticonvulsant doses of polyunsaturated fatty acids on the liver in rats | Q43193590 |
| | Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers | Q43594287 |
| | Selective reduction of excitatory hippocampal sharp waves by docosahexaenoic acid and its methyl ester analog ex-vivo | Q43950437 |
| | Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). | Q44646623 |
| | Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. | Q46011960 |
| | Dose-dependent anticonvulsant effects of linoleic and alpha-linolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. | Q46461190 |
| | Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models | Q46475657 |
| | A randomized trial of polyunsaturated fatty acids for refractory epilepsy. | Q46845645 |
| | Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? | Q46858978 |
| | A minimum of 3 months of dietary fish oil supplementation is required to raise amygdaloid afterdischarge seizure thresholds in rats--implications for treating complex partial seizures | Q48179515 |
| | Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale | Q48525259 |
| | Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses | Q48687126 |
| | Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse | Q48699078 |
| | Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. | Q48890665 |
| | Essential fatty acid preparation reduces cholesterol and fatty acids in rat cortex. | Q52200065 |
| | Adverse effects of antiepileptic drugs | Q55899120 |
| | Non-randomized open trial of eicosapentaenoic acid (EPA), an omega-3 fatty acid, in ten people with chronic epilepsy | Q58449769 |
| | Fish oil attenuates methylmalonate-induced seizures | Q60977198 |
| | Essential fatty acid preparation (SR-3) raises the seizure threshold in rats | Q72680214 |
| | Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation | Q73118879 |
| | Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus | Q73955602 |
| | Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model | Q74446234 |
| | Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients | Q77730476 |
| | Lack of benefit of linoleic and alpha-linolenic polyunsaturated fatty acids on seizure latency, duration, severity or incidence in rats | Q79759928 |
| | n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study | Q81817716 |
| | The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis | Q84095014 |
| P921 | main subject | seizure | Q6279182 |
| P304 | page(s) | 138-143 | |
| P577 | publication date | 2014-03-22 | |
| P1433 | published in | Epilepsy Behavior | Q15746410 |
| P1476 | title | Intraperitoneal administration of docosahexaenoic acid for 14days increases serum unesterified DHA and seizure latency in the maximal pentylenetetrazol model | |
| P478 | volume | 33 | |